Effects of differing antecedent hypoglycemia on subsequent counterregulation in normal humans

Diabetes

Volumn 46, Issue 8, 1997, Pages 1328-1335

  Davis, Stephen N ^a   Shavers, Chris ^a   Mosqueda Garcia, Rogelio ^a   Costa, Fernando ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; GLUCAGON; GLUCOSE; GROWTH HORMONE; INSULIN; NORADRENALIN; PANCREAS POLYPEPTIDE;

ADULT; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CONTROLLED STUDY; HUMAN; HUMAN EXPERIMENT; HYPERINSULINEMIA; HYPOGLYCEMIA; LIPOLYSIS; MALE; NEUROENDOCRINE SYSTEM; NORMAL HUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; SYMPATHETIC NERVE;

EID: 0030837024     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.46.8.1328     Document Type: Article

References (41)

1. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. AT Engl J Med 329:977-986, 1993
2. Amiel SA, Tamborlane WV, Simonson DC, Sherwin R: Defective glucose counterregulation after strict control of insulin-dependent diabetes mellitus. N Engl J Med 316:1376-1383, 1987
3. Amiel SA, Sherwin RW, Simonson DC, Tamborlane W: Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release. Diabetes 37:901-907, 1988
4. Cryer PE: Iatrogenic hypoglycemia as a cause of hypoglycemia-associated autonomie failure in IDDM. Diabetes 41:255-260, 1992
5. Gerich J, Langlois M, Noacco C, Karam J, Forsham P: Lack of a glucagon response to hypoglycemia in diabetes: evidence for an intrinsic pancreatic alpha-cell defect. Science 182:171-173, 1993
6. DeFeo P, Bolli G, Perriello G, DeCosmo S, Compagnucci P, Santeusanio F, Brunetti P, Gerich J, Motolese J, Brunelti P: The adrenergic contribution to glucose counterregulation in type I diabetes mellitus. Diabetes 32:887-693, 1983
7. Davis SN, Shavers C, Costa F, Mosqueda-Garcia R: Role of cortisol in the pathogenesis of deficient counterregulation after antecedent hypoglycemia in normal humans, J Clin Invest 98:680-691, 1996
8. Davis M, Shamoon H: Counterregulatory adaption to recurrent hypoglycemia in normal humans. J Clin Endocrinol Metab 73:995-1001, 1991
9. Widom B, Simonson D: Intermittent hypoglycemia impairs glucose counter-regulation. Diabetes 41:1597-1602, 1992
10. Davis M, Mellman M, Shamoon H: Further defects in counterregulatory responses induced by recurrent hypoglycemia in IDDM. Diabetes 41:1335-1340, 1992
11. Heller S, Cryer PE: Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after one episode of hypoglycemia in nondiabetic humans. Diabetes 40:223-226, 1991
12. Veneman T, Mitrakou A, Mokan M, Cryer PE, Gerich J: Induction of hypoglycemia unawareness by asymptomatic nocturnal hypoglycemia Diabetes 42:1233-1237, 1993
13. Dagago-Jack S, Craft S, Cryer PE: Hypoglycemia-associated autonomie failure in insulin dependent diabetes mellitus. J Clin Invest 91:819-828, 1993
14. Powell A, Sherwin R, Shulman G: Impaired hormonal responses to hypoglycemia in spontaneously diabetic and recurrently hypoglycemic rats. J Clin Invest 92:2667-2674, 1993
15. Abumrad N, Rabin D, Diamond M, Lacy W: Use of a heat superficial hand vein as an alternative site for measurement of amino acid concentration and for the study of glucose and alanine kinetics in man. Metabolism 30:936-940, 1981
16. Sherwin RS, Kramer K, Robin J, Andres R: A model of the kinetics of insulin in man. J Clin Invest 53:1481-1492, 1978
17. DeFronzo R, Tobin J, Andres R: Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 273:E216-E223, 1979
18. Wall J, Steele R, Debodo C, Altszuler N: Effect of insulin on utilization and production of circulating glucose. Am J Physiol 189:43-50, 1957
19. Wallin B, Sundiot G, Eriksson B, Domniak P, Grobecker H, Lindblad L: Plasma noradrenaline correlates by sympathetic muscle nerve activity in normotensive man. Acta Physiol Scand 111:69-73, 1981
20. Fagius J, Niklasson F, Berne C: Sympathetic outflow in human muscle nerves increases during hypoglycemia. Diabetes 35:1126-1129, 1986
21. Fagius J, Berne C: Changes of sympathetic nerve activity induced by 2-deoxy- D-glucose infusion in humans. Am J Physiol 256:E714-E720, 1989
22. Anderson E, Hofiman P, Balon T, Sinkey K, Mark A: Hyperinsulinemia produces both sympathetic and neural activation and vasodilatation in normal humans. J Clin Invest 87:2246-2252, 1992
23. Cherrington AD, Lacy W, Chiasson JL: Effect of glucagon on glucose production during insulin deficiency in the dog. J Clin Invest 62:664-667, 1978
24. Aguilar-Parada E, Eisentraut AM, Unger RH: Pancreatic glucagon secretion in normal and diabetic subjects. Am J Med Sci 257:415-419, 1969
25. Wide L, Porath J: Radioimmunoassay of proteins with the uses of sephadexcoupled antibodies. Biochim Biophys Acta 130:257-260, 1966
26. Causon R, Caruthers M, Rodnight R: Assay of plasma catecholamines by liquid chromatography with electrochemical detection. Anal Biochem 116:223-226, 1982
27. 131I]-labeled human growth hormone of high specific activity. Nature 194:495-496, 1962
28. Hagopian W, Lever E, Cen D, Emmonoud D, Polonsky K, Pugh W, Moosa A, Jaspan J: Predominance of renal and absence of hepatic metabolism of pancreatic polypeptide in the dog. Am J Physiol 245:171-177, 1983
29. Lloyd B, Burrin J, Smythe P, Alberti KGMM: Enzymatic fluorometric continuous flow assays for blood glucose, lactate, pyruvate, alanine, glycerol and 3-hydraxybalyrate. Clin Chem 24:1724-1729, 1978
30. 63NI as tracer. Anal Biochem 26:105-113, 1970
31. Fanelli C, Epitano L, Ramboti A, Pampanelli S, Vincenzo A, Modarelli F, Lepore M, Annibale B, Ciofetta M, Bottini P Porcellati F, Scionti L, Santeusanio F, Brunetti P, Bolli G: Meticulous prevention of hypoglycemia normalizes the glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short term IDDM. Diabetes 42:1683-1689, 1993
32. Fanelli C, Pampanelli S, Epitano L, Rambotti A, Vincenzo A, Modarelli F, Ciofetta M, Lepore M, Annibale B, Torlone E, Pemello G, DeFeo P,Santeusanio F, Brunetti P, Bolli G: Long term recovery from unawareness, deficient counterregulation and lack of cognitive dysfunction during hypoglycemia, following institution of rational, intensive insulin therapy in IDDM. Diabetologia 37:1265-1276, 1994
33. Dagago-Jack S, Rattarasam C, Cryer PE: Reversal of hypoglycemia unawareness, but not defective glucose counterregulation in IDDM. Diabetes 43:1426-1434, 1994
34. Cranston I, Lomas J, Maran A, Macdonald I, Amiel S: Restoration of hypoglycemia awareness in patients with long duration insulin-dependent diabetes. Lancet 344:283-287, 1994
35. Connolly C, Adkins-Marshall B, Neal D, Pugh W, Jaspan J, Cherrington AD: Relationship between decrements in glucose level and metabolic response to hypoglycemia in absence of counterregulatory hormones in the conscious dog. Diabetes 41:1308-1319, 1992
36. Winder W, Maclean P, Chandler S, Huang W, Mills H: Role or epinephrine during insulin induced hypoglycemia in fasted rats. J Appl Physiol 77:270-276, 1994
37. Veneman T, Mitrakou A, Mokan M, Cryer P, Gench JE: Effects of hyperketonemia and hyperlacticacidemia on symptoms, cognitive dysfunction, and counterregulatory hormone responses during hypoglycemia in normal humans. Diabetes 43:1311-1317, 1994
38. Maran A, Cranston I, Lomas J, Macdonald I, Amiel S: Protection by lactate of cerebral function during hypoglycemia Lancet 343:16-20 1994
39. Frizzel RT, Hendrick G, Biggers D, Lacy B, Donahue P, Green D, Carr K, Williams P, Stevenson R, Cherrington AD: Role of gluconeogenesis in sustaining glucose production during hypoglycemia caused by continuous insulin infusion in conscious dogs. Diabetes 37:749-759, 1988
40. Fanelli C, DeFeo P, Procellati F, Perriello G, Torlone E, Santeusanio R, Brunetti P, Bolli G: Adrenergic mechanisms contribute to the late phase of hypoglycemic glucose counterregulation in humans by stimulating lipolysis. J Clin Invest 89:2005-2013, 1992
41. Finegood D, Bergman R, Vranic M: Estimation of endogenous glucose production during hyperinsulinemic euglycemic clamps: comparison of unlabeled and labeled exogenous glucose infusates. Diabetes 36:914-924, 1987